Cosmos Holdings Inc. (OTCQX: COSM) closed the last session at $5.2000 after seeing its market cap rise by 11.83% to $90.13M. Recent trading volume of 11.58K shares for the COSM stock exceeded its average daily volume of 10.60K shares. Moreover, the shares have been fluctuating between $4.7600 and $5.2000. In the pink sheets COSM, 17.33M shares are outstanding compared to 2.92M shares float. Since an investment agreement was signed, COSM’s stock price has soared.
What investments has COSM made?
Cosmos Holdings is a leading multinational pharmaceutical company, which distributes various brands and generic pharmaceuticals, nutraceuticals, OTC drugs, and medical devices through a large, established EU distribution network. COSM develops and markets products that are designed to improve the lives and outcomes of patients. The company has developed a global distribution platform and is currently expanding throughout Europe, Asia, and North America. There are offices and distribution centers in Thessaloniki, Greece, Athens, Greece, and Harlow, UK.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
As part of an investment agreement recently with a subsidiary of Ault Global Holdings, Cosmos Holdings will receive approximately $5.5 million. As a result of the first investment of the company, a convertible promissory note, the company received funding of approximately $500,000. A second investment of $5 million in COSM Series A Preferred Stock is subject to the company’s common stock listing on the Nasdaq Stock Market and other closing conditions.
As a diversified holding company, Ault Global makes investments in undervalued companies and disruptive technologies with global impact to grow. Ault Global offers mission-critical products in the defense/aerospace, industrial, automotive, telecommunications, medical/biopharma, and textiles markets through its wholly and majority-owned subsidiaries and strategic investments. Furthermore, Ault Global offers loan funding to selected entrepreneurs through a subsidiary licensed to make loans.
In the investment agreement, Spartan Capital Securities, LLC acted as a placement agent. Cosmos is a strategic investment for Ault Global, as their business model is scalable and their market opportunity is significant, which will help them accelerate growth and accelerate their transformation to a Nasdaq-listed company.
How COSM will utilize the funds?
The outlook for COSM seems brighter now that Ault Global has provided its support and put its trust in the management team. As COSM expands its distribution network worldwide, it opens up new markets for its proprietary branded pharmaceutical, nutraceutical, and food supplement products. Using the financing, COSM will grow organically in the near future while pursuing its new global distribution strategy online and on e-commerce.